Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GreenLight Biosciences Holdings, PBC - Common Stock (NQ: GRNA )

0.4374 -0.0396 (-8.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 325,933
Open 0.4801
Bid (Size) 0.4210 (12)
Ask (Size) 0.4370 (7)
Prev. Close 0.4770
Today's Range 0.4200 - 0.5200
52wk Range 0.3170 - 11.34
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
From GreenLight Biosciences
Via Globe NewsWire
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
From GreenLight Biosciences
Via Globe NewsWire

Performance

YTD
-61.97%
-61.97%
1 Month
-10.06%
-10.06%
3 Month
-57.53%
-57.53%
6 Month
-80.73%
-80.73%
1 Year
-95.21%
-95.21%

More News

Read More
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
From GreenLight Biosciences
Via Globe NewsWire
Why Greenlight Biosciences Stock Was in the Red Today
Via The Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
From GreenLight Biosciences
Via Globe NewsWire
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
From GreenLight Biosciences
Via Globe NewsWire
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
From GreenLight Biosciences
Via Globe NewsWire
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
From GreenLight Biosciences
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
Via Benzinga
GreenLight Biosciences announces realignment to focus on near-term value drivers
From GreenLight Biosciences
Via Globe NewsWire
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA
From GreenLight Biosciences
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
Via Benzinga
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Peering Into GreenLight Biosciences's Recent Short Interest
Via Benzinga
Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
Via Benzinga
Nasdaq Edges Higher; Crude Oil Falls Sharply
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.